News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
744,540 Results
Type
Article (65136)
Company Profile (421)
Press Release (678983)
Section
Business (208540)
Career Advice (2948)
Deals (36794)
Drug Delivery (119)
Drug Development (84993)
Employer Resources (177)
FDA (17175)
Job Trends (16076)
News (358023)
Policy (35676)
Tag
2024 BioCapital Digital (16)
2024 BioForest Digital (10)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (11)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (19)
2024 Biotech Beach Digital (11)
2024 Biotech Beach Standard (8)
2024 Genetown Digital (7)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (15)
2024 Pharm Country Digital (10)
2024 Pharm Country Standard (6)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2957)
Academic (1)
Accelerated approval (3)
Adcomms (29)
Allergies (82)
Alliances (52842)
ALS (82)
Alzheimer's disease (1437)
Antibody-drug conjugate (ADC) (124)
Approvals (17128)
Artificial intelligence (241)
Autoimmune disease (13)
Automation (14)
Bankruptcy (372)
Best Places to Work (12433)
BIOSECURE Act (21)
Biosimilars (103)
Biotechnology (299)
Bladder cancer (57)
Brain cancer (27)
Breast cancer (248)
Cancer (1912)
Cardiovascular disease (156)
Career advice (2475)
Career pathing (31)
CAR-T (148)
Cell therapy (411)
Cervical cancer (15)
Clinical research (67967)
Collaboration (758)
Compensation (394)
Complete response letters (29)
COVID-19 (2834)
CRISPR (37)
C-suite (194)
Cystic fibrosis (104)
Data (1749)
Decentralized trials (2)
Denatured (31)
Depression (46)
Diabetes (244)
Diagnostics (6759)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (46)
Drug discovery (113)
Drug pricing (117)
Drug shortages (29)
Duchenne muscular dystrophy (69)
Earnings (81691)
Editorial (34)
Employer branding (22)
Employer resources (156)
Events (113938)
Executive appointments (627)
FDA (18188)
Featured Employer (67)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (668)
Gene editing (95)
Generative AI (25)
Gene therapy (289)
GLP-1 (769)
Government (4887)
Grass and pollen (4)
Guidances (45)
Healthcare (20467)
Huntington's disease (24)
IgA nephropathy (23)
Immunology and inflammation (104)
Indications (24)
Infectious disease (2966)
Inflammatory bowel disease (136)
Inflation Reduction Act (10)
Influenza (47)
Intellectual property (73)
Interviews (532)
IPO (17167)
IRA (48)
Job creations (4136)
Job search strategy (2078)
Kidney cancer (10)
Labor market (22)
Layoffs (515)
Leadership (19)
Legal (8640)
Liver cancer (74)
Lung cancer (280)
Lymphoma (124)
Machine learning (2)
Management (62)
Manufacturing (272)
MASH (62)
Medical device (14439)
Medtech (14444)
Mergers & acquisitions (20037)
Metabolic disorders (654)
Multiple sclerosis (65)
NASH (23)
Neurodegenerative disease (88)
Neuropsychiatric disorders (29)
Neuroscience (1918)
NextGen: Class of 2025 (7353)
Non-profit (4990)
Northern California (2254)
Now hiring (31)
Obesity (363)
Opinion (259)
Ovarian cancer (64)
Pain (80)
Pancreatic cancer (71)
Parkinson's disease (126)
Partnered (18)
Patents (190)
Patient recruitment (83)
Peanut (49)
People (60107)
Pharmaceutical (93)
Pharmacy benefit managers (20)
Phase I (21256)
Phase II (29900)
Phase III (22380)
Pipeline (835)
Podcasts (82)
Policy (118)
Postmarket research (2655)
Preclinical (9307)
Press Release (72)
Prostate cancer (89)
Psychedelics (38)
Radiopharmaceuticals (264)
Rare diseases (374)
Real estate (6504)
Recruiting (69)
Regulatory (24130)
Reports (38)
Research institute (2624)
Resumes & cover letters (472)
Rett syndrome (2)
RNA editing (1)
RSV (44)
Schizophrenia (70)
Series A (122)
Series B (73)
Service/supplier (13)
Sickle cell disease (55)
Southern California (1940)
Special edition (17)
Sponsored (33)
Startups (4020)
State (2)
Stomach cancer (14)
Supply chain (62)
The Weekly (51)
United States (20307)
Vaccines (732)
Venture capitalists (33)
Webinars (12)
Weight loss (270)
Women's health (34)
Worklife (16)
Date
Today (199)
Last 7 days (864)
Last 30 days (3088)
Last 365 days (36465)
2025 (5949)
2024 (37366)
2023 (42254)
2022 (53610)
2021 (58354)
2020 (57176)
2019 (50464)
2018 (38447)
2017 (35636)
2016 (35445)
2015 (41085)
2014 (33935)
2013 (29569)
2012 (31169)
2011 (31557)
2010 (29218)
Location
Africa (1010)
Alabama (55)
Alaska (7)
Arizona (184)
Arkansas (12)
Asia (44949)
Australia (7607)
California (5204)
Canada (1786)
China (439)
Colorado (239)
Connecticut (259)
Delaware (117)
Europe (101099)
Florida (761)
Georgia (183)
Hawaii (1)
Idaho (61)
Illinois (515)
India (21)
Indiana (287)
Iowa (6)
Japan (130)
Kansas (103)
Kentucky (26)
Louisiana (10)
Maine (67)
Maryland (824)
Massachusetts (4038)
Michigan (217)
Minnesota (363)
Mississippi (2)
Missouri (77)
Montana (31)
Nebraska (26)
Nevada (56)
New Hampshire (66)
New Jersey (1477)
New Mexico (30)
New York (1480)
North Carolina (982)
North Dakota (8)
Northern California (2254)
Ohio (188)
Oklahoma (14)
Oregon (37)
Pennsylvania (1166)
Puerto Rico (7)
Rhode Island (25)
South America (1375)
South Carolina (14)
South Dakota (1)
Southern California (1940)
Tennessee (85)
Texas (759)
Utah (161)
Virginia (131)
Washington D.C. (58)
Washington State (507)
West Virginia (3)
Wisconsin (53)
744,540 Results for "ecole polytechnique federale de lausanne".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Breakthrough technology for human muscle fatigue measure, Myocene, gets FDA “de novo” approval.
January 30, 2025
·
2 min read
Press Releases
FDA Grants De Novo Marketing Authorization for the Distalmotion Dexter® Surgical Robot
October 28, 2024
·
5 min read
Press Releases
De-identified Health Data Market Rising Valuation to Reach USD 13.80 Billion by 2031
December 16, 2024
·
1 min read
BioCapital
MCRA Supports Onkos Surgical with First FDA De Novo Approval for Antibacterial Coating for Implants
MCRA, the leading privately held independent medical device, diagnostics, and biologics Clinical Research Organization (CRO) and advisory firm is pleased to announce its role in the U.S. Food and Drug Administration’s (FDA) De Novo granting for Onkos Surgical’s antibacterial coating for tumor and revision orthopedic implants.
June 20, 2024
·
4 min read
Business
Echosens Appoints Dr. Victor De Lédinghen as Chief Medical Officer
Echosens announced the appointment of Victor de Lédinghen, MD PhD, as the company’s new Chief Medical Officer.
March 26, 2024
·
2 min read
Biotech Bay
MedGenome announces de novo Genome Assembly and Annotation Grant winners for 2024
MedGenome, a global partner for comprehensive multiomics solutions, in collaboration with PacBio, is pleased to announce Dr. Lauren Esposito of the California Academy of Sciences as the recipient of the ‘2024 de novo genome assembly and annotation grant’.
May 2, 2024
·
4 min read
Press Releases
SONOMOTION ANNOUNCES FDA DE NOVO CLEARANCE FOR ITS STONE CLEAR™ DEVICE
November 13, 2024
·
2 min read
Press Releases
Colossal Secures $200M in Series C Funding From TWG Global on the Back of Numerous World’s First Scientific Breakthroughs on Path to De-Extinction
January 15, 2025
·
18 min read
Press Releases
Lausanne Researchers Combine 10x Genomics’ Chromium and Xenium for Novel Insights into Resistance and Potential Therapeutics for Brain Cancer
September 11, 2024
·
7 min read
Press Releases
Colossal Achieves Multiple Scientific Firsts in Progress Towards Thylacine De-Extinction
October 17, 2024
·
11 min read
1 of 74,454
Next
